Optimizing behavior

for improved health

RECENT NEWS: Tesu Health has been awarded a grant by The Scientific and Technological Research Council of Turkey. Read more…

Evidence-based digital therapeutics for chronic conditions

Digital therapeutics (DTx) are focused on managing specific health conditions using various approaches such as behavior modification

In conditions where they have been investigated, including diabetes, heart disease, and hypertension, DTx have the potential to supplement or even replace traditional prescription medications

Professional support, such as physician supervision and remote learning, improves the quality of behavioral change and helps people sustain healthy behaviors for life

Our Mission

Transform the way that chronic diseases are managed

We are a company on the cutting edge of medical technology. We believe that software is going to change the way that medicine is practiced, the way that chronic diseases are managed, and that we can use it to treat diseases caused by behaviors. We develop evidence-based, clinically validated software that can reverse the progression of diseases and improve quality of life for patients. 

Research Areas

Pipeline

A prescription digital therapeutic for the treatment of prediabetes. Phase: Pilot

 

A prescription digital therapeutic for the treatment of obesity. Phase: Prototyping

A prescription digital therapeutic for the treatment of polycystic ovary syndrome. Phase: Preclinical Research

A prescription digital therapeutic for the treatment of gestational diabetes. Phase: Discovery

A prescription digital therapeutic for the treatment of metabolic syndrome. Phase: Discovery

TESU Academy

Qualified, comprehensive online education help patients improve and maintain the highest standards of their health

Webinars will be announced soon…

Leadership

Hasan Avcu, MD

Co-Founder/Business Lead

Gürkan Caner Birer

Co-Founder/Technology Lead

İlker Tosun, MD

Co-Founder/Operations Lead

Hasan Aydın, MD

Co-Founder/Medical Lead